Zhang Qiang, Fotaki Anastasia, Ghadimi Sona, Wang Yu, Doneva Mariya, Wetzl Jens, Delfino Jana G, O'Regan Declan P, Prieto Claudia, Epstein Frederick H
Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK.
School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
J Cardiovasc Magn Reson. 2024;26(2):101051. doi: 10.1016/j.jocmr.2024.101051. Epub 2024 Jun 22.
Cardiovascular magnetic resonance (CMR) is an important imaging modality for the assessment of heart disease; however, limitations of CMR include long exam times and high complexity compared to other cardiac imaging modalities. Recently advancements in artificial intelligence (AI) technology have shown great potential to address many CMR limitations. While the developments are remarkable, translation of AI-based methods into real-world CMR clinical practice remains at a nascent stage and much work lies ahead to realize the full potential of AI for CMR.
Herein we review recent cutting-edge and representative examples demonstrating how AI can advance CMR in areas such as exam planning, accelerated image reconstruction, post-processing, quality control, classification and diagnosis.
These advances can be applied to speed up and simplify essentially every application including cine, strain, late gadolinium enhancement, parametric mapping, 3D whole heart, flow, perfusion and others. AI is a unique technology based on training models using data. Beyond reviewing the literature, this paper discusses important AI-specific issues in the context of CMR, including (1) properties and characteristics of datasets for training and validation, (2) previously published guidelines for reporting CMR AI research, (3) considerations around clinical deployment, (4) responsibilities of clinicians and the need for multi-disciplinary teams in the development and deployment of AI in CMR, (5) industry considerations, and (6) regulatory perspectives.
Understanding and consideration of all these factors will contribute to the effective and ethical deployment of AI to improve clinical CMR.
心血管磁共振成像(CMR)是评估心脏病的一种重要成像方式;然而,与其他心脏成像方式相比,CMR的局限性包括检查时间长和复杂性高。最近人工智能(AI)技术的进步显示出解决许多CMR局限性的巨大潜力。虽然这些进展显著,但基于AI的方法转化为实际的CMR临床实践仍处于起步阶段,要充分发挥AI在CMR方面的潜力还有很多工作要做。
在此,我们回顾了最近的前沿和代表性实例,展示了AI如何在检查规划、加速图像重建、后处理、质量控制、分类和诊断等领域推动CMR发展。
这些进展可应用于加速和简化几乎每一种应用,包括电影成像、应变分析、延迟钆增强成像、参数映射、三维全心成像、血流成像、灌注成像等。AI是一种基于使用数据训练模型的独特技术。除了回顾文献,本文还在CMR背景下讨论了重要的AI特定问题,包括:(1)用于训练和验证的数据集的属性和特征;(2)先前发表的CMR AI研究报告指南;(3)临床部署的考虑因素;(4)临床医生的职责以及在CMR中开发和部署AI时多学科团队的必要性;(5)行业考虑因素;(6)监管视角。
理解和考虑所有这些因素将有助于有效且符合伦理地部署AI以改善临床CMR。